Catharanthine

Catharanthine
Product Name Catharanthine
CAS No.: 2468-21-5
Catalog No.: CFN99765
Molecular Formula: C21H24N2O2
Molecular Weight: 336.43 g/mol
Purity: >=98%
Type of Compound: Alkaloids
Physical Desc.: White powder
Targets: NO | Calcium Channel | Nicotinic receptor
Source: The herbs of Catharanthus roseus (L.) G.Don
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price: $40/20mg
Catharanthine inhibits nicotinic receptor mediated diaphragm contractions with IC50 of 59.6 μM, it dilates small mesenteric arteries and decreases heart rate and cardiac contractility by inhibition of voltage-operated calcium channels on vascular smooth muscle cells and cardiomyocytes.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Pharmaceuticals (Basel).2022, 15(8):982.
  • Front Plant Sci.2018, 9:1424
  • Planta Med.2019, 85(4):347-355
  • Int. Conference on Med. Sci. and Bio.2017, 17973
  • Antioxidants (Basel).2023, 12(1):189.
  • Biochem Systematics and Ecology2017, 11-18
  • Molecules2022, 27(14):4601
  • Molecules.2023, 28(13):4907.
  • Research Square2021, 10.21203.
  • PLoS One.2021, 16(9):e0257243.
  • Tabernanthine

    Catalog No: CFN96649
    CAS No: 83-94-3
    Price: Inquiry(manager@chemfaces.com)
    Voacangine

    Catalog No: CFN92252
    CAS No: 510-22-5
    Price: $463/5mg
    Conopharyngine

    Catalog No: CFN96068
    CAS No: 76-98-2
    Price: Inquiry(manager@chemfaces.com)
    19(S)-Hydroxyconopharyngine

    Catalog No: CFN96069
    CAS No: 16790-93-5
    Price: Inquiry(manager@chemfaces.com)
    Crassanine

    Catalog No: CFN96176
    CAS No: 16790-92-4
    Price: Inquiry(manager@chemfaces.com)
    Catharanthine

    Catalog No: CFN99765
    CAS No: 2468-21-5
    Price: $40/20mg
    Catharanthine Tartrate

    Catalog No: CFN90318
    CAS No: 2648-21-5
    Price: $100/20mg
    Catharanthine Sulfate

    Catalog No: CFN93298
    CAS No: 70674-90-7
    Price: Inquiry(manager@chemfaces.com)
    19,20-(E)-Vallesamine

    Catalog No: CFN98432
    CAS No: 3368-87-4
    Price: Inquiry(manager@chemfaces.com)
    Vallesamine N-oxide

    Catalog No: CFN99377
    CAS No: 126594-73-8
    Price: Inquiry(manager@chemfaces.com)
    J Pharmacol Exp Ther. 2013 Jun;345(3):383-92.
    Catharanthine dilates small mesenteric arteries and decreases heart rate and cardiac contractility by inhibition of voltage-operated calcium channels on vascular smooth muscle cells and cardiomyocytes.[Pubmed: 23532933]
    Catharanthine is a constituent of anticancer vinca alkaloids. Its cardiovascular effects have not been investigated.
    METHODS AND RESULTS:
    This study compares the in vivo hemodynamic as well as in vitro effects of Catharanthine on isolated blood vessels, vascular smooth muscle cells (VSMCs), and cardiomyocytes. Intravenous administration of Catharanthine (0.5-20 mg/kg) to anesthetized rats induced rapid, dose-dependent decreases in blood pressure (BP), heart rate (HR), left ventricular blood pressure, cardiac contractility (dP/dt(max)), and the slope of the end-systolic pressure-volume relationship (ESPVR) curve. Catharanthine evoked concentration-dependent decreases (I(max) >98%) in endothelium-independent tonic responses of aortic rings to phenylephrine (PE) and KCl (IC(50) = 28 μM for PE and IC(50) = 34 μM for KCl) and of third-order branches of the small mesenteric artery (MA) (IC(50) = 3 μM for PE and IC(50) = 6 μM for KCl). Catharanthine also increased the inner vessel wall diameter (IC(50) = 10 μM) and reduced intracellular free Ca(2+) levels (IC(50) = 16 μM) in PE-constricted MAs. Patch-clamp studies demonstrated that Catharanthine inhibited voltage-operated L-type Ca(2+) channel (VOCC) currents in cardiomyocytes and VSMCs (IC(50) = 220 μM and IC(50) = 8 μM, respectively) of MA. Catharanthine lowers BP, HR, left ventricular systolic blood pressure, and dP/dt(max) and ESPVR likely via inhibition of VOCCs in both VSMCs and cardiomyocytes.
    CONCLUSIONS:
    Since smaller vessels such as the third-order branches of MAs are more sensitive to VOCC blockade than conduit vessels (aorta), the primary site of action of Catharanthine for lowering mean arterial pressure appears to be the resistance vasculature, whereas blockade of cardiac VOCCs may contribute to the reduction in HR and cardiac contractility seen with this agent.
    Biotechnol Prog. 2013 Jul-Aug;29(4):994-1001.
    Interaction between abscisic acid and nitric oxide in PB90-induced catharanthine biosynthesis of catharanthus roseus cell suspension cultures.[Pubmed: 23554409]
    Elicitations are considered to be an important strategy to improve production of secondary metabolites of plant cell cultures. However, mechanisms responsible for the elicitor-induced production of secondary metabolites of plant cells have not yet been fully elucidated.
    METHODS AND RESULTS:
    Here, we report that treatment of Catharanthus roseus cell suspension cultures with PB90, a protein elicitor from Phytophthora boehmeriae, induced rapid increases of abscisic acid (ABA) and nitric oxide (NO), subsequently followed by the enhancement of Catharanthine production and up-regulation of Str and Tdc, two important genes in Catharanthine biosynthesis. PB90-induced Catharanthine production and the gene expression were suppressed by the ABA inhibitor and NO scavenger respectively, showing that ABA and NO are essential for the elicitor-induced Catharanthine biosynthesis. The relationship between ABA and NO in mediating Catharanthine biosynthesis was further investigated. Treatment of the cells with ABA triggered NO accumulation and induced Catharanthine production and up-regulation of Str and Tdc. ABA-induced Catharanthine production and gene expressions were suppressed by the NO scavenger. Conversely, exogenous application of NO did not stimulate ABA generation and treatment with ABA inhibitor did not suppress NO-induced Catharanthine production and gene expressions.
    CONCLUSIONS:
    Together, the results showed that both NO and ABA were involved in PB90-induced Catharanthine biosynthesis of C. roseus cells. Furthermore, our data demonstrated that ABA acted upstream of NO in the signaling cascade leading to PB90-induced Catharanthine biosynthesis of C. roseus cells.
    Biomed Chromatogr. 2015 Jan;29(1):97-102.
    Liquid chromatography mass spectrometry simultaneous determination of vindoline and catharanthine in rat plasma and its application to a pharmacokinetic study.[Pubmed: 24828449]
    Vinblastine and vincristine, both of which are bisindole alkaloids derived from vindoline and Catharanthine, have been used for cancer chemotherapy; their monomeric precursor molecules are vindoline and Catharanthine. A simple and selective liquid chromatography mass spectrometry method for simultaneous determination of vindoline and Catharanthine in rat plasma was developed.
    METHODS AND RESULTS:
    Chromatographic separation was achieved on a C18 (2.1 × 50 mm, 3.5 μm) column with acetonitrile-0.1% formic acid in water as mobile phase with gradient elution. The flow rate was set at 0.4 mL/min. An electrospray ionization source was applied and operated in positive ion mode; selective ion monitoring mode was used for quantification. Mean recoveries were in the range of 87.3-92.6% for vindoline in rat plasma and 88.5-96.5% for Catharanthine. Matrix effects for vindoline and Catharanthine were measured to be between 95.3 and 104.7%. Coefficients of variation of intra-day and inter-day precision were both <15%. The accuracy of the method ranged from 93.8 to 108.1%.
    CONCLUSIONS:
    The method was successfully applied in a pharmacokinetic study of vindoline and Catharanthine in rats. The bioavailability of vindoline and Catharanthine were 5.4 and 4.7%, respectively.
    Pd-C-II

    Catalog No: CFN95003
    CAS No: N/A
    Price: $358/5mg
    Buddlenoid A

    Catalog No: CFN95025
    CAS No: 142750-32-1
    Price: $368/5mg
    3''-O-Galloylmyricitrin

    Catalog No: CFN95057
    CAS No: 143202-36-2
    Price: $333/5mg
    1-Phenyl-2-propanol

    Catalog No: CFN95129
    CAS No: 14898-87-4
    Price: $30/20mg
    Rhamnocitrin 3-glucoside

    Catalog No: CFN95134
    CAS No: 41545-37-3
    Price: $318/10mg
    Henricine

    Catalog No: CFN95244
    CAS No: 107783-46-0
    Price: $413/5mg
    Apigenin 7-[rhamnosyl-(1->2)-galacturonide]

    Catalog No: CFN95352
    CAS No: 124167-97-1
    Price: $318/10mg
    (-)-5'-Methoxyisolariciresinol 3alpha-O-beta-glucopyranoside

    Catalog No: CFN95403
    CAS No: 143236-03-7
    Price: $318/5mg
    2,6-Dihydroxyacetophenone-4-O-[4',6'-(S)-hexahydroxydiphenoyl]-beta-D-glucose

    Catalog No: CFN95470
    CAS No: 1781226-44-5
    Price: $318/5mg
    3',3'''-Binaringenin

    Catalog No: CFN95558
    CAS No: 145399-99-1
    Price: $413/5mg